On this page:
NCCIH supports research centers to conduct multidisciplinary research not readily supported through other funding mechanisms.
NCCIH Centers Summaries
Centers of Excellence for Research on Complementary and Integrative Health
The purpose of NCCIH’s Centers of Excellence for Research on Complementary and Integrative Health (CERCIH) program is to support synergistic, multidisciplinary, multi-project research programs that have strong potential to significantly advance the mission of NCCIH and address areas of high research priority, as described in its current Strategic Plan [nccih.nih.gov/about/plans]. Basic, mechanistic, and translational approaches are appropriate for the CERCIH, but should not propose clinical trials of efficacy/effectiveness. Studies proposing to use human participants are allowed, and indeed for some complementary health interventions, using human participants may be the only current way to conduct mechanistic studies.
Centers for Advancing Research on Botanicals and Other Natural Products (CARBON) Program
Botanical Dietary Supplement Research Centers (BDSRC)
These centers use cutting-edge techniques to conduct research on botanicals in dietary supplements. The long-term goal is to support development of preclinical data needed in preparation for definitive clinical trials on botanical products. The centers focus on botanicals traditionally used for health maintenance and those that have shown promise for improving resilience.
Centers for Advancing Natural Products Innovation and Technology (CANPIT)
The goal of this initiative is to strengthen technologies for natural products research. The CANPIT is expected to serve a leadership role by coordinating scientific discourse and disseminating methodology and best practices to the natural product research community. The CANPIT centers collaborate directly with other grantees through CANPIT Technology Demonstration Projects.
Center of Excellence for Natural Product Drug Interaction Research
The goal of this program is to develop a definitive approach to determining the clinical relevance of pharmacokinetic interactions between natural products and medications. The center will 1) study four to six natural products that may interact with common medications; 2) work collaboratively with NIH to plan a definitive assessment of the clinical relevance of any interactions; 3) establish a set of best practices for the study of natural product interactions with drugs; and 4) develop and maintain a database and public access portal for the resources created through this research.